Supply Chain Latest News news and information

A heated takeover battle has erupted around generic-drug company Actavis as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities.
FULL STORY »

Cancer researchers are growing increasingly enthusiastic about harnessing the body's own immune system to fight tumors.
FULL STORY »

The Food and Drug Administration has approved a new injectable drug that uses radiation to treat advanced prostate cancer that has spread to the bones.
FULL STORY »

The Indian generic drugmaker Ranbaxy, which already operates under an unprecedented consent decree banning sales of many of its products in the U.S., agreed to plead guilty in federal court and pay $500 million to resolve allegations of shoddy factory inspections and poor quality control.
FULL STORY »